Molecular Mechanisms Regulating the Defects in Fragile X Syndrome Neurons Derived from Human Pluripotent Stem Cells

被引:65
|
作者
Halevy, Tomer [1 ]
Czech, Christian [2 ]
Benvenisty, Nissim [1 ]
机构
[1] Hebrew Univ Jerusalem, Inst Life Sci, Dept Genet, Azrieli Ctr Stem Cells & Genet Res, IL-91904 Jerusalem, Israel
[2] Roche Innovat Ctr, CH-4070 Basel, Switzerland
来源
STEM CELL REPORTS | 2015年 / 4卷 / 01期
基金
以色列科学基金会;
关键词
MENTAL-RETARDATION PROTEIN; RESTRICTIVE SILENCER FACTOR; GENOME-WIDE ANALYSIS; NEURAL STEM; IN-VIVO; PROGENITOR CELLS; GENE-EXPRESSION; TARGET GENES; FMR1; TRANSCRIPTION;
D O I
10.1016/j.stemcr.2014.10.015
中图分类号
Q813 [细胞工程];
学科分类号
摘要
Fragile X syndrome (FXS) is caused by the absence of the fragile X mental retardation protein (FMRP). We have previously generated FXS-induced pluripotent stem cells (iPSCs) from patients' fibroblasts. In this study, we aimed at unraveling the molecular phenotype of the disease. Our data revealed aberrant regulation of neural differentiation and axon guidance genes in FXS-derived neurons, which are regulated by the RE-1 silencing transcription factor (REST). Moreover, we found REST to be elevated in FXS-derived neurons. As FMRP is involved in the microRNA (miRNA) pathway, we employed miRNA-array analyses and uncovered several miRNAs dysregulated in FXS-derived neurons. We found hsa-mir-382 to be downregulated in FXS-derived neurons, and introduction of mimic-mir-382 into these neurons was sufficient to repress REST and upregulate its axon guidance target genes. Our data link FMRP and REST through the miRNA
引用
收藏
页码:37 / 46
页数:10
相关论文
共 50 条
  • [1] Modeling Fragile X Syndrome Using Human Pluripotent Stem Cells
    Mor-Shaked, Hagar
    Eiges, Rachel
    GENES, 2016, 7 (10):
  • [2] Functional Deficiencies in Fragile X Neurons Derived from Human Embryonic Stem Cells
    Telias, Michael
    Kuznitsov-Yanovsky, Liron
    Segal, Menahem
    Ben-Yosef, Dalit
    JOURNAL OF NEUROSCIENCE, 2015, 35 (46) : 15295 - 15306
  • [3] Human pluripotent stem cells in modeling human disorders: the case of fragile X syndrome
    Vershkov, Dan
    Benvenisty, Nissim
    REGENERATIVE MEDICINE, 2017, 12 (01) : 53 - 68
  • [4] Human pluripotent stem cell models of Fragile X syndrome
    Bhattacharyya, Anita
    Zhao, Xinyu
    MOLECULAR AND CELLULAR NEUROSCIENCE, 2016, 73 : 43 - 51
  • [5] Epigenetic modifications in human fragile X pluripotent stem cells; Implications in fragile X syndrome modeling
    Gerhardt, Jeannine
    BRAIN RESEARCH, 2017, 1656 : 55 - 62
  • [6] Differential Modeling of Fragile X Syndrome by Human Embryonic Stem Cells and Induced Pluripotent Stem Cells
    Urbach, Achia
    Bar-Nur, Ori
    Daley, George Q.
    Benvenisty, Nissim
    CELL STEM CELL, 2010, 6 (05) : 407 - 411
  • [7] Functional changes of AMPA responses in human induced pluripotent stem cell-derived neural progenitors in fragile X syndrome
    Achuta, Venkat Swaroop
    Moykkynen, Tommi
    Peteri, Ulla-Kaisa
    Turconi, Giorgio
    Rivera, Claudio
    Keinanen, Kari
    Castren, Maija L.
    SCIENCE SIGNALING, 2018, 11 (513)
  • [8] Ascorbic Acid Ameliorates Molecular and Developmental Defects in Human-Induced Pluripotent Stem Cell and Cerebral Organoid Models of Fragile X Syndrome
    Gunapala, Keith M.
    Gadban, Aseel
    Noreen, Faiza
    Schar, Primo
    Benvenisty, Nissim
    Taylor, Verdon
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (23)
  • [9] Molecular convergence between Down syndrome and fragile X syndrome identified using human pluripotent stem cell models
    Susco, Sara G.
    Ghosh, Sulagna
    Mazzucato, Patrizia
    Angelini, Gabriella
    Beccard, Amanda
    Barrera, Victor
    Berryer, Martin H.
    Messana, Angelica
    Lam, Daisy
    Hazelbaker, Dane Z.
    Barrett, Lindy E.
    CELL REPORTS, 2022, 40 (10):
  • [10] Engineered hematopoietic and immune cells derived from human pluripotent stem cells
    Chang, Yun
    Hummel, Sydney N.
    Jung, Juhyung
    Jin, Gyuhyung
    Deng, Qing
    Bao, Xiaoping
    EXPERIMENTAL HEMATOLOGY, 2023, 127 : 14 - 27